Sunrest Lifescience Ltd
Sunrest Lifescience Ltd Live Price Chart
Performance
| Previous Close | ₹ 38 |
| High | ₹ 40.6 |
| Volume | 6400 |
| 52W Range | ₹ - ₹ |
| Open | ₹ 40.6 |
| Low | ₹ 39.6 |
| Market Cap | ₹ 30.04 Cr |
Sunrest Lifescience Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
Sunrest Lifescience Ltd Fundamentals
| ROCE | 15.936 |
| P/E Ratio | 11.000 |
| P/B Ratio | 0.990 |
| Industry P/E | 0.990 |
| Debt to Equity | 51.431 |
| ROE | 16.025 |
| EPS | 3.600 |
| Dividend Yield | 0.000 |
| Book Value | 39.945 |
| Face Value | 10.000 |
Sunrest Lifescience Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 33.1229 | 29.4839 | 24.6705 | 26.9099 | 16.9491 |
| Total Expenses | 30.5145 | 28.8912 | 21.9265 | 25.8595 | 16.7255 |
| Profit After Tax | 1.9998 | 0.2257 | 2.0431 | 0.7771 | 0.1655 |
Sunrest Lifescience Ltd Shareholding Pattern
| Promoter Holdings | 53.505 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 36.018 % |
| Others - | 10.477 % |
About Sunrest Lifescience Ltd
Sunrest Lifescience Limited was originally incorporated as 'Sunrest Lifescience Private Limited' as a Private Company vide Certificate of Incorporation dated October 30, 2017, with the Registrar of Companies, Gujarat. Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Sunrest Lifescience Limited' on March 21, 2023. The Company is engaged in marketing of OTC generic pharmaceutical products into domestic market. The Company operate in different States of India such as Maharashtra, Gujarat, Madhya Pradesh, Orissa and Rajasthan. It deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Dental Cure, Anti Malerial, Anti Diabetic, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The Company gets product manufactured from one of their Group Company, Trilend Pharmaceuticals Private Limited. Apart from this, Company acquired 11,000 equity shares of Trilend, constituting 9.90% of its paid-up share capital. The Company came up with its Initial Public Offering of 12,91,200 Equity Shares of Rs 10/- each by raising funds aggregating to Rs 10.84 Crore through Fresh Offer in November, 2023. The Company has acquired 51.45% stake in the Hetvi Lifesciences Private Limited, making it a ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 44.01 +0.88 (+2.04%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 514.25 -2.8 (-0.54%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 7,106.50 -29.5 (-0.41%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 588.10 +28 (+5%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,175.00 -175 (-0.66%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,423.50 +3.5 (+0.25%) |
FAQs on Sunrest Lifescience Ltd
1. Can I buy Sunrest Lifescience Ltd from PL Capital? ›
2. Does Sunrest Lifescience Ltd pay dividends? ›
3. What is the current share price of Sunrest Lifescience Ltd ? ›
4. What is the 52-week high and low of Sunrest Lifescience Ltd ? ›
Start SIP in Sunrest Lifescience Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
